Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zentalis Pharmaceuticals, LLC

1.38
-0.1200-8.00%
Post-market: 1.400.0200+1.45%19:13 EDT
Volume:717.41K
Turnover:1.03M
Market Cap:99.29M
PE:-0.44
High:1.54
Open:1.47
Low:1.37
Close:1.50
Loading ...

Stifel Nicolaus Sticks to Their Buy Rating for Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
27 Mar

Oppenheimer Remains a Buy on Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
27 Mar

Zentalis Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

BRIEF-Zentalis Pharmaceuticals Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing

Reuters
·
27 Mar

Zentalis Pharmaceuticals Inc Files for Mixed Shelf of up to $250 Mln - SEC Filing

THOMSON REUTERS
·
27 Mar

Zentalis Pharmaceuticals FY24 EPS ($2.33) Up From ($4.47) YoY)

Benzinga
·
27 Mar

Press Release: Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates

Dow Jones
·
27 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
21 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
17 Mar

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

GlobeNewswire
·
15 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
10 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
05 Mar

BRIEF-Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
04 Mar

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Mar

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

THOMSON REUTERS
·
03 Mar

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

GlobeNewswire
·
03 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
28 Feb

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
21 Feb

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting

Business Wire
·
19 Feb

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Feb